Drug Profile


Alternative Names: Bradycor; CP 0127; SB 238592; Septicor

Latest Information Update: 28 Sep 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cortech
  • Class Analgesics; Anti-inflammatories
  • Mechanism of Action Bradykinin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Brain injuries; Brain oedema; Cancer pain; Migraine; Postoperative pain; Shock; Stroke; Systemic inflammatory response syndrome

Most Recent Events

  • 28 Sep 1998 Discontinued-III for Systemic inflammatory response syndrome in USA (Unknown route)
  • 28 Sep 1998 Discontinued-Preclinical for Shock in USA (Unknown route)
  • 28 Sep 1998 Discontinued-Unspecified for Asthma in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top